Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kian Gen Azma (KGA) is a biotechnology company based in Tehran, Iran, that specializes in the production of molecular biology reagents and diagnostic kits. The company's product portfolio includes high-quality DNA and RNA extraction kits, PCR master mixes, and specialized reagents for genetic research and clinical diagnostics. KGA plays a significant role in the Iranian healthcare market by providing localized solutions for molecular testing, particularly in the fields of oncology, infectious diseases, and prenatal screening. During the COVID-19 pandemic, the company was a key supplier of viral transport media and PCR-based detection kits. KGA also offers laboratory services and technical support to research institutions and clinical labs across the region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kian Gen Azma.